Amarin Corporation plc (AMRN) CEO Karim Mikhail Presents at 40th Annual J.P. Morgan Healthcare Conference (Transcript)

Amarin Corporation plc (NASDAQ:AMRN) 40th Annual J.P. Morgan Healthcare Conference January 11, 2022 8:15 AM ET

Company Participants

Karim Mikhail - President, CEO & Director

Conference Call Participants

Jessica Fye - JPMorgan Chase & Co.

Jessica Fye

Hey, good morning, everyone. My name is Jess Fye. I'm one of the senior biotech analysts at JPMorgan. We're continuing the 40th Healthcare Conference today with Amarin. I'm joined by the company's CEO, Karim Mikhail. He's going to give a presentation, and then we're going to do some Q&A afterwards. If you want to ask a question, there's a blue ‘Ask a Question’ button on your screen. Submit one to the portal. It'll come to me and I can ask those questions to management after the presentation. So with that, let me pass it over to Karim.

Karim Mikhail

Thank you, Jessica, and good morning, everyone. In today's presentation, I may make forward-looking statements. For a complete list of risk factors associated with investing in Amarin, please refer to our SEC filing.

So at Amarin, we have a bold vision to stop heart disease from being a leading cause of death. And in today's world, and I'm today on Slide #4, it is very bold as a vision because people don't realize it, but cardiovascular disease is really maybe the most enormous and worsening public health problem we have today.

And whether you're sitting in the U.S. or in Europe or anywhere internationally, the number of patients that are impacted by cardiovascular disease and the economic burden that the different countries carry today, especially at the time with COVID, where it is a significant burden, having to see all these additional cardiovascular challenges that are added to the -- because of COVID.

So it's definitely a huge challenge everywhere in the world. And up